Other Events ·
Fractyl Health, Inc. reported one-year results from its REMAIN-1 Midpoint Cohort study, showing the Revita DMR System…
GUTSFractyl Health, Inc.
Fractyl Health, Inc. reported one-year results from its REMAIN-1 Midpoint Cohort study, showing the Revita DMR System can reduce weight regain after GLP-1 discontinuation. In the full mITT population (N=45), Revita reduced weight regain by approximately 40% compared to sham (7.8% vs 13.0% body weight regain). Participants with complete duodenal ablation (>14 cm) maintained 81% of GLP-1-induced weight loss at one year. Fractyl Health, Inc. is a medical device company focused on metabolic health and weight management solutions.